" class="no-js "lang="en-US"> Asgard Therapeutics - Medtech Alert
Friday, March 29, 2024
Asgard Therapeutics | Pharmtech Focus

Asgard Therapeutics

About Asgard Therapeutics

Asgard Therapeutics

Asgard Therapeutics is specialized in R&D and in the use of direct cell reprogramming technologies for cancer immunotherapy.

Related Story

Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics

November 9 2021

Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]